← Archive
IN FORCE

195 Publice Notice dated 10.12.2021 2021-Dec-10 169 KB

Reliability

In force — no superseding record on file.

Document text

F.No X-11026/030/2019-PRO (1) Government of India Directorate General of Health Services Central Drugs Standard Control Organisation (Public Relation Office)

FDA Bhawan, New Delhi Date: 10-12-2021

Public Notice

In continuation to this Directorate’s Public Notice of even number dated 04.10.2019 regarding public hearing by respective division at Public Relation Office, CDSCO (HQ), New Delhi is operational in following manner to strengthen the process of regulatory guidance to stakeholders and innovators:

|Day||Officials ofthe Division in||Officials ofthe Division in||
|---|---|---|---|---|---|
|||forenoon||afternoon|||
|Monday||Medical Devices& IVD|||CDAC& Blood Bank||
|Tuesday|||New Drugs &SND|||Foc 6Ger||
|Wednesday||Cosmetics&Veterinary—||"International Celis&CDAC||
|Thursday||Import& Registration|||Biological & LVP||
|Friday||—Ayush& Ethics Committee<br>|<br>| CDAC&BA/BEExportt<br>ee||||

All stakeholders may avail the facilities as per their requirement.

==> picture [19 x 15] intentionally omitted <==

----- Start of picture text -----<br> 1<br>----- End of picture text -----<br>

(Dr. V.G.Somani) Drugs Controller General (India)

  • Copy To,

    1. JDC(SER)/JDC(PBN)/JDC (AKP)

    2. All DDC(I)s/ADC(I)s at CDSCO(HQ)

    3. IT cell -for uploading on web site of CDSCO

    4. Guard File

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 24600 --apply.

Citation copied